ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2027

Whole Exome Trio Sequencing Implicates DOCK2 in Juvenile Idiopathic Arthritis

Laura A McIntosh1,2, Yoshinori Fukui3, Thomas A. Griffin4, Kenneth Kaufman1,2,5, Jarek Meller6,7, Sherry Thornton8, Halima Moncrieffe1,2 and Susan D Thompson1,2, 1Center for Autoimmune Genomics and Etiology (CAGE), Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Department of Pediatrics, University of Cincinnati, Cincinnati, OH, 3Division of Immunogenetics, Department of Immunobiology and Neuroscience, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan, 4Levine Children’s Hospital at Carolinas Medical Center, Charlotte, NC, 5US Department of Veterans Affairs Medical Center, Cincinnati, OH, 6Division of Biomedical Informatics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 7Department of Environmental Health, University of Cincinnati, Cincinnati, OH, 8Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Arthritis, genetics, juvenile idiopathic arthritis (JIA), mouse model and neutrophils

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Pediatric Rheumatology – Basic Science Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease of childhood and has a strong genetic component to disease risk. Genome-wide association studies have been the primary method for understanding genetic risk in complex diseases, including JIA, but they do not fully explain disease inheritance. This study focuses on identifying de novo mutations (DNMs) among sporadic oligoarticular and rheumatoid factor-negative (RF–) polyarticular JIA patients that may contribute to disease pathogenesis.

Methods: Whole exome sequencing (WES) and downstream bioinformatic analyses were used to identify rare, nonsynonymous DNMs among 10 oligoarticular or RF– polyarticular JIA patient-parent trios. All cases met either the International League of Associations for Rheumatology (ILAR) or the American College of Rheumatology (ACR) classification for JIA. Analysis of these mutations implicated a role for DOCK2 in JIA. The impact of DOCK2 genetic deficiency in C57BL/6 mice on arthritis development and progression was evaluated using the autoantibody-induced, K/BxN serum-transfer model.

Results: Sanger sequencing confirmed 15 nonsynonymous DNMs identified by WES among 8 JIA trios. One DNM was located in DOCK2, whose gene product complexes with the gene products of two JIA-associated loci identified by association testing. In mice, DOCK2 deficiency resulted in decreased clinical measures of disease, while also reducing histopathological features in the forepaws, metacarpophalangeal joints, and knee joints induced by the K/BxN serum-transfer model. DOCK2 expression drives neutrophil infiltration into the hindpaws that can further exacerbate disease.

Conclusion: DOCK2 is a molecular determinant of autoantibody-induced arthritis that augments disease severity and pathology through a mechanism resulting in neutrophil infiltration. Furthermore, this study demonstrates the value of rare variant detection in understanding the genetic architecture of JIA.


Disclosure: L. A. McIntosh, None; Y. Fukui, None; T. A. Griffin, None; K. Kaufman, None; J. Meller, None; S. Thornton, None; H. Moncrieffe, None; S. D. Thompson, None.

To cite this abstract in AMA style:

McIntosh LA, Fukui Y, Griffin TA, Kaufman K, Meller J, Thornton S, Moncrieffe H, Thompson SD. Whole Exome Trio Sequencing Implicates DOCK2 in Juvenile Idiopathic Arthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/whole-exome-trio-sequencing-implicates-dock2-in-juvenile-idiopathic-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/whole-exome-trio-sequencing-implicates-dock2-in-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology